NEW YORK — Cambrian Bioworks, a developer of genomics and molecular diagnostics laboratory products based in India, said Thursday that it has closed a $1.5 million seed financing round.
The round was led by the Irani Family Office with participation from Cambrian Bioworks CEO Vaibhav Hegde.
Cambrian Bioworks offers a range of products including kits for DNA extraction and isolation, whole-genome sequencing, and sample collection. The company said it will use the new funding to support its research and development and to speed up the development of automated molecular diagnostics platforms.